200 related articles for article (PubMed ID: 16608382)
1. Improving access to medicines in poor countries: the role of universities.
Chokshi DA
PLoS Med; 2006 Apr; 3(6):e136. PubMed ID: 16608382
[TBL] [Abstract][Full Text] [Related]
2. The responsibility of research universities to promote access to essential medicines.
't Hoen EF
Yale J Health Policy Law Ethics; 2003; 3(2):293-300. PubMed ID: 14577145
[No Abstract] [Full Text] [Related]
3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
4. The GO License: only part of the solution.
Batson A; Milstien JB
Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
[TBL] [Abstract][Full Text] [Related]
5. Taking TRIPS to India--Novartis, patent law, and access to medicines.
Mueller JM
N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
[No Abstract] [Full Text] [Related]
6. Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
Bird RC
J Law Med Ethics; 2009; 37(2):209-21. PubMed ID: 19493067
[TBL] [Abstract][Full Text] [Related]
7. Access to essential drugs, human rights and global justice.
Shalev C
Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
[No Abstract] [Full Text] [Related]
8. Access denied to essential medicines in developing world.
Ahmad K
Lancet Infect Dis; 2002 Dec; 2(12):711. PubMed ID: 12467674
[No Abstract] [Full Text] [Related]
9. Access to medicines versus access to treatment: the case of type 1 diabetes.
Beran D; McCabe A; Yudkin JS
Bull World Health Organ; 2008 Aug; 86(8):648-9. PubMed ID: 18797626
[No Abstract] [Full Text] [Related]
10. Academic patents and access to medicines in developing countries.
Sampat BN
Am J Public Health; 2009 Jan; 99(1):9-17. PubMed ID: 19008514
[TBL] [Abstract][Full Text] [Related]
11. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
12. Innovation and the WHO's essential medicines list: giving credit where credit is due.
Wertheimer AI; Santella TM
Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562
[No Abstract] [Full Text] [Related]
13. Commentary: will generic drug stores improve access to essential medicines for the poor in India?
Kotwani A
J Public Health Policy; 2010 Jul; 31(2):178-84. PubMed ID: 20535100
[No Abstract] [Full Text] [Related]
14. [Patents and availability of essential drugs].
Carné X
Med Clin (Barc); 2007 Nov; 129(16):617-8. PubMed ID: 18001674
[No Abstract] [Full Text] [Related]
15. The performance and problems of the Turkish pharmaceutical industry: is there a need to develop a national drug policy?
Kisa A
J Med Syst; 2001 Oct; 25(5):309-18. PubMed ID: 11508904
[TBL] [Abstract][Full Text] [Related]
16. Patent pooling to increase access to essential medicines.
Burrone E; Gotham D; Gray A; de Joncheere K; Magrini N; Martei YM; Gore C; Kieny MP
Bull World Health Organ; 2019 Aug; 97(8):575-577. PubMed ID: 31384076
[No Abstract] [Full Text] [Related]
17. Reprivatizing pharmaceutical supplies in Africa.
Turshen M
J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
[TBL] [Abstract][Full Text] [Related]
18. The role of university technology transfer operations in assuring access to medicines and vaccines in developing countries.
Nelsen L
Yale J Health Policy Law Ethics; 2003; 3(2):301-8. PubMed ID: 14577146
[No Abstract] [Full Text] [Related]
19. Pharmaceuticals, patents, publicity...and philanthropy?
Lancet; 2009 Feb; 373(9665):693. PubMed ID: 19249610
[No Abstract] [Full Text] [Related]
20. [Access to essential drugs in developing countries].
Rojo P
Gac Sanit; 2001; 15(6):540-5. PubMed ID: 11858791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
